Sobi Shows Positive EMBRACE Data | US FDA Grants Breakthrough Tag to Sanofi

Novo Nordisk Boosts Access with ₹202/Day Ozempic & Wegovy

Probiotic Boosts Sleep | CBD Therapy Shows Early Promise

Everest Medicines Signs Deal with Corxel Pharmaceuticals for Cardamyst Nasal Spray

Hoth Therapeutics Reports Positive MASLD Data | POLY-ACS Trial Highlights Polypill Strategy

Novo Nordisk’s CagriSema bested by Lilly’s Zepbound in head-to-head trial.

Lundbeck Completes Enrollment in Phase 3 MASCOT Trial Ahead of Schedule

Capricor to Present at 2026 MDA Conference | Neurent NEUROMARK Trial Positive

Tzield sBLA Gets Priority Review | Endeavor Health in Landmark Live CTE Study

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous

Ascletis Gets FDA OK for ASC30 Study | AZ’s Saphnelo Shows Strong Phase III SLE Data

CPP Phase 3 Trial Positive | Edgewise Advances EDG-7500 in Hypertrophic Cardiomyopathy

Abbott Laboratories Launches ICRAS Tool | Inimmune Corporation Starts Phase 2 Allergy Trial

AstraZeneca Tozorakimab Meets Phase III Endpoints in COPD Trials

Amydis Wins $2.5M National Institutes of Health Grant for TDP-43 Biomarker Research

Recross Cardio Enrolls First Patient | Granata Bio Reports Strong Phase III GRACE Enrollment

Aplagon Doses First Patient in Phase 2a APAC Trial | Meiji Seika Pharma Starts Phase 1 Study

Eli Lilly’s Orforglipron Tops Oral Semaglutide | FDA Reviews Vanda’s Imsidolimab

Kidney Drug Expansion Falls Short | Ionis Steps Up Angelman Awareness Campaign

Efzimfotase Alfa Shows Phase III Success | European Commission Approves Sanofi Rezurock

Functional Gut Clinic Launches Trials Unit | Pegrizeprument Gets Orphan Drug Status

Japan Reviews GSK’s Hep B Drug | Neurizon Starts NUZ-001 HEALEY ALS Study

BioVersys’ AlpE TB Study Published in NEJM | Merck Shares Positive Enflonsia RSV Data

Industry Leaders- Media coverage | Lifescience Intellipedia | Chemxpert Database | Clival Database

Roche Columvi Combo Delivers Sustained 3-Year Survival Benefit – Clinical News Update

Myrtelle’s Canavan Trial Success | NeuroSense Marks Alzheimer’s Progress – Clinical News Update

Draig Begins Phase 2 for Depression | WHO Unveils New Bacterial Treatment Data– Clinical News Update

$2M ALS Trial Support Announced | Ionis Wins Breakthrough Status for Zilganersen – Clinical News

AstraZeneca Hits Phase 3 Milestone | Skye Bioscience Unveils CBeyond Results– Clinical News Update

Valneva Advances Zika Vaccine | Calico Earns FDA Orphan Drug – Clinical News Update Nod

GC Biopharma Secures IND OK in Korea for COVID-19 mRNA Vaccine Trial

ADC Therapeutics to Update on LOTIS-7 Trial – Clinical News Update

Thermo Fisher Enrolls First Patient in PPD CorEvitas Alzheimer’s Registry

AbbVie’s ABBV-295 Shows Positive Phase 1 Data | Acurx Launches New CDI Trial

MetaVia Presents DA-1726 Data | Nanoscope’s Optogenetic Trial Shows Safety – Clinical News Update

Gefurulimab Succeeds in Phase 3 Trial | GC Biopharma’s Anthrax Vaccine Shines – Clinical News Update